Figure 8. Computational simulation of Akt phosphrylation (pAkt) in 10 µmol/liter erlotinib (IC 50) in NSCLC that involve loss of PTEN (at 50 ng/ml EGF).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.